News
BBC
25.63
0.00%
0.00
Weekly Report: what happened at BBC last week (0415-0419)?
Weekly Report · 2d ago
Weekly Report: what happened at BBC last week (0408-0412)?
Weekly Report · 04/15 11:54
Weekly Report: what happened at BBC last week (0401-0405)?
Weekly Report · 04/08 12:00
Weekly Report: what happened at BBC last week (0325-0329)?
Weekly Report · 04/01 11:57
Weekly Report: what happened at BBC last week (0318-0322)?
Weekly Report · 03/25 12:01
Weekly Report: what happened at BBC last week (0311-0315)?
Weekly Report · 03/18 11:58
Weekly Report: what happened at BBC last week (0304-0308)?
Weekly Report · 03/11 11:54
Why Biotech Stocks May Be Ready For A Recovery
Biotech stocks have struggled in recent quarters as high interest rates take a toll on the capital-intensive sector. Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with MoneyTalk's Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a recovery.
Seeking Alpha · 03/09 08:59
5 Best ETF Areas of Last Week
NASDAQ · 03/05 13:42
Top & Flop ETF Areas of Wall Street's Best February in Decade
NASDAQ · 03/04 13:00
Weekly Report: what happened at BBC last week (0226-0301)?
Weekly Report · 03/04 11:57
Are Healthcare Stocks A Risky Prescription In A U.S. Election Year?
Seeking Alpha · 02/27 18:15
Weekly Report: what happened at BBC last week (0219-0223)?
Weekly Report · 02/26 12:15
Weekly Report: what happened at BBC last week (0212-0216)?
Weekly Report · 02/19 12:18
Weekly Report: what happened at BBC last week (0205-0209)?
Weekly Report · 02/12 12:04
Weekly Report: what happened at BBC last week (0129-0202)?
Weekly Report · 02/05 12:16
Weekly Report: what happened at BBC last week (0122-0126)?
Weekly Report · 01/29 11:59
Weekly Report: what happened at BBC last week (0115-0119)?
Weekly Report · 01/22 12:05
Weekly Report: what happened at BBC last week (0108-0112)?
Weekly Report · 01/15 12:00
Week In Review: China Biopharmas Book $9B In Deals During JP Morgan Conference Week
Shanghai Argo Biopharma entered two agreements with Novartis for a total value of $4.2 billion. San Diego’s Ambrx Biopharmas will be acquired by Johnson & Johnson for $2billion. GSK plans to acquire Aiolos Bio for $1 billion upfront and up to $400 million.
Seeking Alpha · 01/14 08:40
More
Webull provides a variety of real-time BBC stock news. You can receive the latest news about Virtus LifeSci Biotech Clinical Trls ETF through multiple platforms. This information may help you make smarter investment decisions.